Fitzgerald Joseph Michael
Officer at BSX
- Sold, on record
- $78.5M
- Dollars the filings state
- Form 4 sales
- 25
- Latest Nov 3, 2025
- Form 144 notices
- 12
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- BSXBOSTON SCIENTIFIC CORPOfficer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice BSXNoticeAug 1, 2025 2025
Filed to sell 50,000 shares ($5.2M)
Fitzgerald Joseph Michael, Officer
10b5-1 plan1.5x usual sizeFiling
- 2 Form 4 sale BSXRoutineAug 1, 2025 same day
Sold 50,000 shares at $104.63 ($5.2M)
Fitzgerald Joseph Michael, EVP & Group Pres, Cardiology
10b5-1 planSold 21.9% of holdings ($23.9M position)178,342 shares left1.5x usual sizeFollows a Form 144Filing
- 3 Form 144 notice BSXNoticeSep 2, 2025 +32 days
Filed to sell 50,000 shares ($5.3M)
Fitzgerald Joseph Michael, Officer
10b5-1 plan1x usual sizeFiling
- 4 Form 4 sale BSXRoutineSep 2, 2025 same day
Sold 50,000 shares at $105.43 ($5.3M)
Fitzgerald Joseph Michael, EVP & Group Pres, Cardiology
10b5-1 planSold 21.9% of holdings ($24.1M position)178,342 shares left1x usual sizeFollows a Form 144Filing
- 5 Form 144 notice BSXNoticeOct 1, 2025 +29 days
Filed to sell 50,000 shares ($4.9M)
Fitzgerald Joseph Michael, Officer
10b5-1 plan1x usual sizeFiling
- 6 Form 4 sale BSXRoutineOct 1, 2025 same day
Sold 50,000 shares at $98.47 ($4.9M)
Fitzgerald Joseph Michael, EVP & Group Pres, Cardiology
10b5-1 planSold 21.9% of holdings ($22.5M position)178,342 shares left1x usual sizeFollows a Form 144Filing
- 7 Form 144 notice BSXNoticeNov 3, 2025 +33 days
Filed to sell 50,000 shares ($5M)
Fitzgerald Joseph Michael, Officer
10b5-1 plan1x usual sizeFiling
- 8 Form 4 sale BSXRoutineNov 3, 2025 same day
Sold 50,000 shares at $99.47 ($5M)
Fitzgerald Joseph Michael, EVP & Group Pres, Cardiology
10b5-1 planSold 21.9% of holdings ($22.7M position)178,342 shares left1x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (37)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2025 | Nov 4, 2025 | BSX | EVP & Group Pres, Cardiology | Form 4 sale | 50,000 | $5M | 21.9% | Routine | SEC |
| Nov 3, 2025 | Nov 3, 2025 | BSX | Officer | Form 144 notice | 50,000 | $5M | Notice | SEC | |
| Oct 1, 2025 | Oct 1, 2025 | BSX | EVP & Group Pres, Cardiology | Form 4 sale | 50,000 | $4.9M | 21.9% | Routine | SEC |
| Oct 1, 2025 | Oct 1, 2025 | BSX | Officer | Form 144 notice | 50,000 | $4.9M | Notice | SEC | |
| Sep 2, 2025 | Sep 3, 2025 | BSX | EVP & Group Pres, Cardiology | Form 4 sale | 50,000 | $5.3M | 21.9% | Routine | SEC |
| Sep 2, 2025 | Sep 2, 2025 | BSX | Officer | Form 144 notice | 50,000 | $5.3M | Notice | SEC | |
| Aug 1, 2025 | Aug 4, 2025 | BSX | EVP & Group Pres, Cardiology | Form 4 sale | 50,000 | $5.2M | 21.9% | Routine | SEC |
| Aug 1, 2025 | Aug 1, 2025 | BSX | Officer | Form 144 notice | 50,000 | $5.2M | Notice | SEC | |
| Jul 1, 2025 | Jul 2, 2025 | BSX | EVP & Group Pres, Cardiology | Form 4 sale | 50,000 | $5.3M | 21.9% | Unusual | SEC |
| Jul 1, 2025 | Jul 1, 2025 | BSX | Officer | Form 144 notice | 50,000 | $5.3M | Notice | SEC | |
| Jun 4, 2025 | Jun 4, 2025 | BSX | EVP & Group Pres, Cardiology | Form 4 sale | 56,372 | $5.8M | 24.0% | Unusual | SEC |
| Jun 4, 2025 | Jun 4, 2025 | BSX | Officer | Form 144 notice | 56,372 | $5.8M | Notice | SEC | |
| Dec 10, 2024 | Feb 13, 2025 | BSX | EVP & Group Pres, Cardiology | Form 4 sale | 20 | $2k | 0.0% | No plan | SEC |
| Oct 7, 2024 | Oct 8, 2024 | BSX | EVP & Group Pres, Cardiology | Form 4 sale | 132,527 | $11.3M | 45.2% | Unusual | SEC |
| Oct 7, 2024 | Oct 7, 2024 | BSX | Officer | Form 144 notice | 132,527 | $11.3M | Notice | SEC | |
| Aug 28, 2024 | Aug 29, 2024 | BSX | EVP & Group Pres, Cardiology | Form 4 sale | 14,132 | $1.1M | 7.4% | Routine | SEC |
| Aug 28, 2024 | Aug 28, 2024 | BSX | Officer | Form 144 notice | 14,132 | $1.1M | Notice | SEC | |
| Jan 12, 2024 | Jan 16, 2024 | BSX | EVP & Group Pres, Cardiology | Form 4 sale | 11,660 | $700k | 6.3% | No plan | SEC |
| Jan 12, 2024 | Jan 12, 2024 | BSX | Officer | Form 144 notice | 11,660 | $700k | Notice | SEC | |
| Dec 29, 2023 | Jan 2, 2024 | BSX | EVP & Group Pres, Cardiology | Form 4 sale | 81,940 | $4.7M | 32.0% | Unusual | SEC |
| Dec 29, 2023 | Dec 29, 2023 | BSX | Officer | Form 144 notice | 81,940 | $4.7M | Notice | SEC | |
| Sep 20, 2023 | Sep 21, 2023 | BSX | EVP & Group Pres, Cardiology | Form 4 sale | 15,867 | $873k | 7.4% | No plan | SEC |
| Sep 20, 2023 | Sep 20, 2023 | BSX | Officer | Form 144 notice | 15,867 | $873k | Notice | SEC | |
| May 16, 2023 | May 17, 2023 | BSX | EVP & Group Pres, Cardiology | Form 4 sale | 63,339 | $3.4M | 22.8% | No plan | SEC |
| May 16, 2023 | May 16, 2023 | BSX | Officer | Form 144 notice | 63,339 | $3.4M | Notice | SEC | |
| Dec 13, 2022 | Dec 14, 2022 | BSX | EVP & Group Pres, Cardiology | Form 4 sale | 79,264 | $3.8M | 26.8% | Unusual | SEC |
| Jul 27, 2021 | Jul 27, 2021 | BSX | EVP & Pres, Interven Cardio | Form 4 sale | 105,490 | $4.7M | 34.1% | Unusual | SEC |
| Sep 11, 2020 | Sep 14, 2020 | BSX | EVP & Pres, Interven Cardio | Form 4 sale | 77,640 | $3.2M | 26.0% | Unusual | SEC |
| Dec 13, 2019 | Dec 16, 2019 | BSX | EVP & President, Rhythm Mgmt | Form 4 sale | 107,692 | $4.8M | 34.9% | Unusual | SEC |
| Jul 1, 2019 | Jul 2, 2019 | BSX | EVP & President, Rhythm Mgmt | Form 4 sale | 22,579 | $979k | 10.0% | Plan not stated | SEC |
| Feb 12, 2019 | Feb 13, 2019 | BSX | EVP & President, Rhythm Mgmt | Form 4 sale | 44,236 | $1.8M | 18.3% | Plan not stated | SEC |
| Feb 7, 2018 | Feb 8, 2018 | BSX | EVP & President, Rhythm Mgmt | Form 4 sale | 85,227 | $2.3M | 35.9% | Unusual | SEC |
| May 3, 2016 | May 4, 2016 | BSX | EVP & President, CRM | Form 4 sale | 79,960 | $1.7M | 46.5% | Unusual | SEC |
| Nov 9, 2015 | Nov 10, 2015 | BSX | EVP & President, CRM | Form 4 sale | 26,220 | $487k | 20.1% | Plan not stated | SEC |
| Feb 10, 2015 | Feb 11, 2015 | BSX | EVP & President, CRM | Form 4 sale | 61,208 | $897k | 42.0% | Unusual | SEC |
| Nov 1, 2013 | Nov 5, 2013 | BSX | SVP & President, CRM | Form 4 sale | 9,236 | $108k | 9.9% | Plan not stated | SEC |
| Aug 16, 2013 | Aug 19, 2013 | BSX | SVP & President, CRM | Form 4 sale | 9,202 | $101k | 9.0% | Plan not stated | SEC |